Current Status of Internal Cardioversion in Atrial Fibrillation.

For more than 30 years transthoracic external cardioversion has been an established method for the restoration of sinus rhythm in patients with persistent atrial fibrillation. It was first described by Lown in 19631. Though the success rate for external cardioversion ranges from 60-90 %2,3,4, there...

Full description

Bibliographic Details
Published in:	Indian Pacing and Electrophysiology Journal
Main Authors:	Andreas Plewan, Eckhard Alt
Format:	Article
Language:	English
Published:	Elsevier 2002-04-01
Subjects:	atrial fibrillation internal cardioversion
Online Access:	http://www.ipej.org/0202/alt.htm

Similar Items

THE IMPORTANCE OF EARLY CARDIOVERSION OF PAROXYSMAL ATRIAL FIBRILLATION
by: Franc Verovnik
Published: (2002-01-01)

Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation – the FinCV-4 study
by: Samuli Jaakkola, et al.
Published: (2022-12-01)

Cardioversion of atrial fibrillation does not affect obstructive sleep apnea
by: Niklas Höglund, et al.
Published: (2017-04-01)

Rivaroxaban in atrial fibrillation cardioversion: an update
by: Lavalle C, et al.
Published: (2019-05-01)

What Governs Immediate or Delayed Cardioversion of Atrial Fibrillation by Direct Current Shock?
by: Amar T. AL-Hamdi, et al.
Published: (2024-12-01)

Incidence and Determinants of Spontaneous Cardioversion of Early Onset Symptomatic Atrial Fibrillation
by: Marco Valerio Mariani, et al.
Published: (2022-10-01)

Serial electrical cardioversion for refractory atrial fibrillation with rapid ventricular response post ablation
by: Katherine Liu, et al.
Published: (2025-10-01)

Prevalence and risk factors associated with decompensated heart failure after successful elective cardioversion for atrial fibrillation and atrial flutter
by: Christina Healy, et al.
Published: (2024-11-01)

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY
by: B. A. Tatarskii
Published: (2015-12-01)

Efficiency and safety of pharmacological cardioversion for atrial fibrillation
by: Aleksei V. Tarasov
Published: (2021-04-01)

Comparison of efficacy of pharmacological cardioversion with antazoline and propafenone versus electrical cardioversion in atrial fibrillation during cryoablation
by: Konrad Klocek, et al.
Published: (2024-03-01)

Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation
by: N. A. Novikova, et al.
Published: (2016-11-01)

Investigation of predictive parameters for recurrence in patients undergoing electrical cardioversion for atrial fibrillation
by: Levent Pay, et al.
Published: (2025-04-01)

MR-proANP, sST2, BNP and sinus rhythm maintenance 1 year after electrical cardioversion for atrial fibrillation
by: Marc Badoz, et al.
Published: (2025-08-01)

Comparison of clinical outcomes of Ibutilide-guided cardioversion and direct current synchronized cardioversion after radiofrequency ablation of persistent atrial fibrillation
by: Xing Liu, et al.
Published: (2023-11-01)

Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion
by: Ozan Demirel, et al.
Published: (2023-05-01)

Early Risk of Stroke in Patients Undergoing Acute Versus Elective Cardioversion for Atrial Fibrillation
by: Tomas Forslund, et al.
Published: (2021-08-01)

The Role of Biphasic Shocks for Transthoracic Cardioversion of Atrial Fibrillation
by: Simon J Walsh, et al.
Published: (2005-10-01)

Value of transoesophageal echocardiography-guided approach to electrical cardioversion of atrial fibrillation
by: O. S. Kalashnikovа
Published: (2013-06-01)

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety
by: N. Yu. Mironov, et al.
Published: (2019-01-01)

The clinical condition and functional performance of the heart in patients with persistent atrial fibrillation after electrical cardioversion.
by: K. А. Pysarevska
Published: (2016-03-01)

The clinical condition and functional performance of the heart in patients with persistent atrial fibrillation after electrical cardioversion
by: Pysarevska K.О.
Published: (2016-03-01)

Predictors of long-term outcomes in patients with persistent atrial fibrillation undergoing electrical cardioversion
by: Mohammad Reza Dehghani, et al.
Published: (2024-03-01)

Predicting the Outcomes of External Direct Current Cardioversion for Atrial Fibrillation: A Narrative Review of Current Evidence
by: Ibrahim Antoun, et al.
Published: (2025-04-01)

Pharmacological cardioversion of atrial fibrillation paroxysm in elderly and senile patients at prehospital stage
by: Andrei V. Syrov
Published: (2021-03-01)

Ventricular arrhythmias after atrial fibrillation electrical cardioversion: A multicenter study
by: Oholi Tovia-Brodie, MD, et al.
Published: (2024-11-01)

Body surface mapping of P-waves in sinus rhythm to predict recurrence following cardioversion for atrial fibrillation
by: Ibrahim Antoun, et al.
Published: (2024-07-01)

Atrial fibrillation: real-life experience of a rhythm control with electrical cardioversion in a community hospital
by: Artemiy Okhotin, et al.
Published: (2024-04-01)

Automatically optimized vectorcardiographic features are associated with recurrence of atrial fibrillation after electrical cardioversion
by: F. Plesinger, et al.
Published: (2025-01-01)

Usefulness of risk scores and predictors of atrial fibrillation recurrence after elective electrical cardioversion
by: Daniel Águila‐Gordo, et al.
Published: (2024-01-01)

Association of iron deficiency with atrial fibrillation recurrence after pharmacological cardioversion
by: M. Kh. Valeev, et al.
Published: (2023-07-01)

Left atrial volume index: A predictor of atrial fibrillation recurrence following direct current cardioversion – A systematic review and meta-analysis
by: Dipesh Raniga, et al.
Published: (2024-04-01)

Model for predicting long-term sinus rhythm retention after electrical cardioversion in patients with persistent atrial fibrillation.
by: K. O. Pysarevska, et al.
Published: (2017-12-01)

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness
by: N. Yu. Mironov, et al.
Published: (2018-11-01)

Serum galectin-3 level predicts early recurrence following successful direct-current cardioversion in persistent atrial fibrillation patients
by: Kadri Murat Gürses, et al.
Published: (2019-10-01)

Feasibility and safety of the direct current cardioversion at the time of left atrial appendage occlusion for patients with atrial fibrillation
by: Xian Sai Meng, et al.
Published: (2023-09-01)

Analysis of drug-induced and spontaneous cardioversions reveals similar patterns leading to termination of atrial fibrillation
by: Arne van Hunnik, et al.
Published: (2024-07-01)

Effectiveness of сavutilide in restoring sinus rhythm in patients with atrial fibrillation and flutter following prior unsuccessful electrical cardioversion
by: Kh. M. Dzaurova, et al.
Published: (2025-06-01)

A new score for detection of early cardioversion using intravenous amiodarone in recent onset atrial fibrillation
by: Hisham Samir Roshdy, et al.
Published: (2016-12-01)

The value of uric acid/albumin ratio to predict cardioversion success in atrial fibrillation patients
by: Ahmet Lutfu Sertdemir, et al.
Published: (2025-04-01)